Correspondence 0001193125-23-122207 from Alector, Inc. (ALEC) (CIK 0001653087) (ALEC)
Alector, Inc. (ALEC) (CIK 0001653087)
Date: April 27, 2023 · CIK: 0001653087 · Accession: 0001193125-23-122207
AI Filing Summary & Sentiment
File numbers found in text: 333-270126
Show Raw Text
CORRESP 1 filename1.htm CORRESP April 27, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Jason Drory Re: Alector, Inc. Registration Statement on Form S-3 Filed February 28, 2023 File No. 333-270126 Acceleration Request Requested Date: May 1, 2023 Requested Time: 4:05 p.m. Eastern Time, or as soon thereafter as practicable Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Alector, Inc. (the “Company”) hereby respectfully requests that the above-referenced Registration Statement on Form S-3 (File No. 333-270126) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, Professional Corporation, by calling Michael Coke at (650) 565-3596. Please direct any questions or comments regarding this acceleration request to Michael Coke. Sincerely, Alector, Inc. By: /s/ Arnon Rosenthal Arnon Rosenthal, Ph.D. Co-founder and Chief Executive Officer cc: Michael E. Coke, Wilson Sonsini Goodrich & Rosati, Professional Corporation Alector 131 Oyster Point Blvd, Suite 600 South San Francisco, CA 94080 alector.com